121 related articles for article (PubMed ID: 62790)
1. Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.
Romualdez AG; Ward PA; Torikata T
J Immunol; 1976 Nov; 117(5 Pt.2):1762-6. PubMed ID: 62790
[TBL] [Abstract][Full Text] [Related]
2. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
[TBL] [Abstract][Full Text] [Related]
3. Further studies on the C5-derived chemotactic factor for tumor cells.
Romualdez AG; Ward PA
Prog Clin Biol Res; 1976; 9():65-71. PubMed ID: 193134
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.
Orr W; Varani J; Ward PA
Am J Pathol; 1978 Nov; 93(2):405-22. PubMed ID: 568888
[TBL] [Abstract][Full Text] [Related]
5. Antileukotactic properties of tumor cells.
Brozna JP; Ward PA
J Clin Invest; 1975 Sep; 56(3):616-23. PubMed ID: 239965
[TBL] [Abstract][Full Text] [Related]
6. Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.
Venge P; Olsson I
J Immunol; 1975 Dec; 115(6):1505-8. PubMed ID: 1184964
[TBL] [Abstract][Full Text] [Related]
7. Generation of biologically active, complement-(C5) derived peptides by cathepsin H.
Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM
J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181
[TBL] [Abstract][Full Text] [Related]
8. Two distinct chemotactic factor inactivators in human serum.
Till G; Ward PA
J Immunol; 1975 Feb; 114(2 pt 2):843-7. PubMed ID: 46254
[TBL] [Abstract][Full Text] [Related]
9. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
Clark RA; Klebanoff SJ
J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
[TBL] [Abstract][Full Text] [Related]
10. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation.
Muhlfelder TW; Niemetz J; Kreutzer D; Beebe D; Ward PA; Rosenfeld SI
J Clin Invest; 1979 Jan; 63(1):147-50. PubMed ID: 762243
[TBL] [Abstract][Full Text] [Related]
11. Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.
Orr FW; Delikatny EJ; Mokashi S; Krepart GV; Stiver HG
Am J Pathol; 1983 Jan; 110(1):41-7. PubMed ID: 6185003
[TBL] [Abstract][Full Text] [Related]
12. The effect of a novel C5 inhibitor (K-76 COONa) on tumor cell chemotaxis.
Bumpers HL; Baum J
J Lab Clin Med; 1983 Sep; 102(3):421-7. PubMed ID: 6886523
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
Desai U; Dickey B; Varani J; Kreutzer DL
J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the protease activity in the chemotactic factor inactivator.
Ward PA; Ozols J
J Clin Invest; 1976 Jul; 58(1):123-9. PubMed ID: 6489
[TBL] [Abstract][Full Text] [Related]
15. A unique complement derived chemotactic factor for tumor cells.
Romualdez AG; Ward PA
Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4128-32. PubMed ID: 172896
[TBL] [Abstract][Full Text] [Related]
16. Effects of passage, growth phase, and heterogeneity of a tumor cell population on tumor cell chemotaxis.
Oda D; Orr FW
Invasion Metastasis; 1984; 4(4):189-97. PubMed ID: 6533092
[TBL] [Abstract][Full Text] [Related]
17. Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor.
Lett-Brown MA; Boetcher DA; Leonard EJ
J Immunol; 1976 Jul; 117(1):246-52. PubMed ID: 932427
[TBL] [Abstract][Full Text] [Related]
18. Regulatory dysfunction in leukotaxis.
Ward PA; Johnson KJ; Kreutzer DL
Am J Pathol; 1977 Sep; 88(3):701-10. PubMed ID: 142429
[TBL] [Abstract][Full Text] [Related]
19. Generation of a fibroblast chemotactic factor in serum by activation of complement.
Postlethwaite AE; Snyderman R; Kang AH
J Clin Invest; 1979 Nov; 64(5):1379-85. PubMed ID: 91624
[TBL] [Abstract][Full Text] [Related]
20. Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5.
Orr W; Phan SH; Varani J; Ward PA; Kreutzer DL; Webster RO; Henson PM
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1986-9. PubMed ID: 287038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
